The Brief

The Bank of England's MPC voted 8-1 to hold Bank Rate at 3.75% in April, with Chief Economist Huw Pill breaking ranks to vote for a rise to 4% — the first dissent in favour of a hike since the current cycle began.

The Iran conflict has pushed Brent crude above $110 per barrel, driving CPI to 3.3% in March against a 2% target, while the Bank now projects inflation peaking at 3.6–3.7% by year-end and GDP growth at 0.7–0.8% for 2026.

The MPC's dilemma is structurally different from 2022's inflation episode — then, rate hikes could credibly address domestic demand; now, the inflation is imported and energy-driven, meaning tighter policy suppresses growth without reliably reducing the price level.

The 18 June decision is therefore genuinely live — not because hiking will fix the inflation, but because the MPC's credibility on the 2% target may require it to be seen to act regardless of whether the instrument is well-matched to the problem.

The Steel Industry (Nationalisation) Bill passed its third reading in the House of Commons on 9 June, just 26 days after introduction, and advances to the Lords for a second reading on 16 June.

The bill grants ministers a standing power to transfer steel company shares or property into public ownership where deemed in the public interest — a mechanism explicitly linked to British Steel, into which the government has already injected £484 million in working capital since April 2025.

The fast-track timetable signals that the government views maintaining blast furnace capacity as a national security matter rather than a conventional industrial policy choice, a framing that insulates the policy from standard market-intervention objections but creates a precedent with significant reach into sectors from water to semiconductors.

How the Lords handle the compensation provisions will be the critical test — overly generous terms to Jingye risks political embarrassment, while insufficient terms risks legal challenge and a lasting chilling effect on foreign direct investment in UK strategic assets.

US ingredients group Ingredion announced a recommended all-cash acquisition of London-listed Tate & Lyle at 595 pence per share on 8 June, valuing the equity at £2.7 billion and implying an enterprise value of £3.7 billion — a 59% premium to the pre-announcement closing price.

The deal broadens Ingredion's specialty ingredients platform across texturants, sugar reduction and fortification, with the combined entity targeting $130 million in annual net cost synergies by 2030 and adjusted EPS accretion in the first year post-completion.

That a 59% premium was required to secure a recommended offer illustrates the structural discount at which UK-listed companies have been trading relative to US peers — a discount that makes British businesses systematically attractive acquisition targets regardless of their underlying quality.

Tate & Lyle's own 2021 restructuring into specialty ingredients means Ingredion is paying a full specialty-business multiple for a transformation UK public markets never adequately priced — the acquisition is less a discovery of hidden value than a transfer of value from British shareholders to a US strategic buyer.